Singulex Garners $7,475,513 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1650 Harbor Bay Parkway Alameda, CA 94502
  • Company Description
    Singulex is an early stage biotechnology company with research and development laboratories in St. Louis and commercial operations in Hayward, California.

    Singulex has obtained exclusive license to all intellectual property around its core technology and has further fortified this position. Our business model builds upon both the immediate and longer term needs in therapeutic discovery/development and eventually human disease management through improved diagnostics.

  • Website
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount includes Subordinated Convertible Promissory Notes and Warrants, incl. (i) the shares of Preferred Stock issuable upon conversion of the Notes and/or upon exercise of the Warrants and (ii) the shares of Common Stock issuable upon conversion of the Preferred Stock. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy